Vertex Pharmaceuticals (VRTX)

R&D Expense Growth

3.35%

Quarterly · Period ending:

VRTX logo

VRTX R&D Expense Growth

Latest reported3.35%
VRTX Quarterly R&D Growth (QoQ) (0.00% → 3.35%)
High-resolution chart · PNG

VRTX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
3.3486%
-1.2427%
-5.6675%
5.4988%
-0.1327%
-1.9025%
14.0199%
-83.8267%
525.4417%
-35.9399%
56.8643%
-3.8496%
20.6841%
6.9875%
7.6124%
7.4821%
-0.4974%
-13.1355%
40.6174%
-64.9098%
208.5906%
-2.2742%
-5.4535%
17.2402%
-6.1535%
-6.5588%
-13.659%
46.6529%
11.6649%
-22.4698%
32.4865%
-2.0804%
8.6874%
1.2682%
-32.5935%
57.1758%
5.8078%
10.107%
-9.7752%
1.6095%
5.9204%
-17.5786%
26.0451%
10.018%
3.8307%
7.0167%
5.5117%
-15.0552%
-5.9352%
-4.2651%
9.2061%
2.7475%
1.9991%
2.3396%
6.4688%
1.8403%
0.0881%
5.3278%
-1.3827%
9.4076%
8.9426%
-6.0845%
-0.9071%
9.8993%
8.4399%
5.7546%
2.3446%
-5.1668%
-2.96%
-0.7116%
11.2659%
2.2308%
10.9529%
-0.6572%
-10.5538%
-5.3148%
2.7222%
21.4685%
13.5577%
5.3315%
21.3399%
10.3348%
7.1835%
7.1314%
3.3464%
5.8768%
11.1847%
2.824%
13.8572%
-8.9509%
-8.52%
-1.335%
-4.5277%
-9.708%
16.2103%
8.7569%
-1.0123%
5.3714%
17.0768%
37.1375%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.